Skip to content Skip to footer

Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL)

Langgan

Surat Berita

订阅我们的月讯

Subscribe to our

Newsletter